The Role of Neutrophils, Lymphocytes and Monocytes in Ischemic Heart Disease: Friend or Foe?

References (53)

1. 1 Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 [DOI]
2. 2 Neutrophils and immunity: challenges and opportunities [DOI]
3. 3 Atherosclerosis: Recent developments [DOI]
4. 4 Biomarkers of Cardiovascular Disease [DOI]
5. 5 Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study [DOI]
6. 6 Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure [DOI]
7. 7 Immunity, atherosclerosis and cardiovascular disease [DOI]
8. 8 Targeting inflammation in atherosclerosis — from experimental insights to the clinic [DOI]
9. 9 Neutrophil Extracellular Trap (NET) Impact on Deep Vein Thrombosis [DOI]
10. 10 Multiple Roles for Neutrophils in Atherosclerosis [DOI]
11. 11 Epidemiological Features of Cardiovascular Disease in Asia [DOI]
12. 12 Inflammation and Immunity in Diseases of the Arterial Tree [DOI]
13. 13 Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis [DOI]
14. 14 Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction [DOI]
15. 15 Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes [DOI]
16. 16 Low Lymphocyte Count and Cardiovascular Diseases [DOI]
17. 17 Blood Monocytes and Their Subsets: Established Features and Open Questions [DOI]
18. 18 Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates [DOI]
19. 19 Neutrophil function in ischemic heart disease. [DOI]
20. 20 Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers [DOI]
21. 21 Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis? [DOI]
22. 22 Large and small platelets—(When) do they differ? [DOI]
23. 23 Usefulness of Complete Blood Count (CBC) to Assess Cardiovascular and Metabolic Diseases in Clinical Settings: A Comprehensive Literature Review [DOI]
24. 24 Role of Monocytes in Heart Failure and Atrial Fibrillation [DOI]
25. 25 Atherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly [DOI]
26. 26 Epidemiology and risk factors of patients with types of acute coronary syndrome presenting to a tertiary care hospital in Sri Lanka [DOI]
27. 27 Matrix metalloproteinases in coronary artery disease and myocardial infarction [DOI]
28. 28 The Role of Neutrophils in the Immune System: An Overview [DOI]
29. 29 Global, Regional, and National Burdens of Ischemic Heart Disease Attributable to Smoking From 1990 to 2019 [DOI]
30. 30 Nature versus Number: Monocytes in Cardiovascular Disease [DOI]
31. 31 Neutrophils in cardiovascular disease [DOI]
32. 32 Monocytes and macrophages in cardiac injury and repair [DOI]
33. 33 T lymphocytes [DOI]
34. 34 Immunomodulatory properties of cimetidine: Its therapeutic potentials for treatment of immune-related diseases [DOI]
35. 35 Neutrophils in atherosclerosis [DOI]
36. 36 Diagnostic Value of D-Dimer in Acute Myocardial Infarction Among Patients With Suspected Acute Coronary Syndrome [DOI]
37. 37 Lymphocytes and the Cellular Basis of Adaptive Immunity
38. 38 ANEMIA [DOI]
39. 39 Macrophages derived from LPS-stimulated monocytes from individuals with subclinical atherosclerosis were characterized by increased pro-inflammatory activity [DOI]
40. 40 Multimodality Imaging in the Detection of Ischemic Heart Disease in Women [DOI]
41. 41 Multiple risk factors and population attributable risk for ischemic heart disease mortality in the United States, 1971–1992 [DOI]
42. 42 Risk Factors for Coronary Artery Disease [DOI]
43. 43 HEMOGLOBIN AND HEMATOCRIT [DOI]
44. 44 Coronary Artery Disease [DOI]
45. 45 D-Dimer Is Associated With Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease and Preserved Ejection Fraction [DOI]
46. 46 Epidemiology of Ischemic Heart Disease [DOI]
47. 47 Lifestyle Factors Influencing Coronary Heart Disease [DOI]
48. 48 [Coronary arteriography and coronary angioplasty in stable ischemic heart disease. Value in the prediction and prevention of future acute myocardial infarction].
49. 49 Coronary heart disease symptoms
50. 50 Primed to Understand Fibrinogen in Cardiovascular Disease [DOI]
51. 51 Macrophage profiling in atherosclerosis: understanding the unstable plaque [DOI]
52. 52 Assessing Global, Regional, and National Time Trends and Associated Risk Factors of the Mortality in Ischemic Heart Disease Through Global Burden of Disease 2019 Study: Population-Based Study [DOI]
53. 53 Role Played by Biochemical and Hematological Parameters in the Prediction of Cardiovascular Risk [DOI]

Cited by 0

No indexed citations yet.

Related research

• Elevated Peripheral Blood IL-6 Levels: A Novel Biomarker for Assessing Inflammation and Exacerbation Risk in Pediatric Bronchial Asthma — shares topic coverage
• Adult Zebrafish Model of Wound Inflammation to Study Wound Healing Potency of Curcuma longa Extracts — shares topic coverage
• The Effect of Phorbol 12-Myristate 13-Acetate on CD11b and CD62-L Cell Surface Expression of Neutrophils and Monocytes — shares topic coverage
• Microbicidal Activity of Neutrophils Isolated from HIV Patients — shares topic coverage
• Temporal Variations in Density and Distribution of Neutrophils with Associated Morphological Changes in Uterus at All Stages of Estrus Cycle in Mice — shares topic coverage